Idexx Laboratories (IDXX) Net Cash Flow Growth (1y) (2010 - 2026)
Idexx Laboratories (IDXX) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | -260.86% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 73.93% |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | -115.29% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | -58.16% |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | -441.96% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 84.25% |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 138.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.93% |
| Mar 31, 2026 | 117.44% |
| Dec 31, 2025 | -164.83% |
| Sep 30, 2025 | 144.94% |
| Jun 30, 2025 | -361.58% |
| Mar 31, 2025 | -132.62% |
| Dec 31, 2024 | -109.02% |
| Sep 30, 2024 | -148.75% |
| Jun 30, 2024 | -76.31% |
| Mar 31, 2024 | -3,021.01% |
| Dec 31, 2023 | 1,472.03% |
| Sep 30, 2023 | 2,333.07% |
| Jun 30, 2023 | 126.88% |
| Mar 31, 2023 | -102.83% |
| Dec 31, 2022 | 7,091.35% |
| Sep 30, 2022 | 89.28% |
| Jun 30, 2022 | 32.90% |
| Mar 31, 2022 | 299.18% |
| Dec 31, 2021 | -99.95% |
| Sep 30, 2021 | -221.20% |